Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Accumulated Expenses (2021 - 2025)

LifeStance Health (LFST) has disclosed Accumulated Expenses for 5 consecutive years, with $143.3 million as the latest value for Q4 2025.

  • Quarterly Accumulated Expenses rose 22.02% to $143.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $143.3 million through Dec 2025, up 22.02% year-over-year, with the annual reading at $143.3 million for FY2025, 22.02% up from the prior year.
  • Accumulated Expenses for Q4 2025 was $143.3 million at LifeStance Health, up from $113.8 million in the prior quarter.
  • The five-year high for Accumulated Expenses was $143.3 million in Q4 2025, with the low at $50.4 million in Q2 2021.
  • Average Accumulated Expenses over 5 years is $91.0 million, with a median of $83.7 million recorded in 2023.
  • The sharpest move saw Accumulated Expenses soared 51.06% in 2024, then dropped 0.51% in 2025.
  • Over 5 years, Accumulated Expenses stood at $60.0 million in 2021, then rose by 26.08% to $75.6 million in 2022, then skyrocketed by 35.46% to $102.5 million in 2023, then rose by 14.62% to $117.5 million in 2024, then rose by 22.02% to $143.3 million in 2025.
  • According to Business Quant data, Accumulated Expenses over the past three periods came in at $143.3 million, $113.8 million, and $129.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.